The store will not work correctly when cookies are disabled.
2-[4-(7-Bromo-5-fluoro-2,3-dioxo-2,3-dihydroindol-1-ylmethyl)benzyl]isoselenourea hydrobromide
ID: ALA4764389
Chembl Id: CHEMBL4764389
PubChem CID: 155715218
Max Phase: Preclinical
Molecular Formula: C17H14Br2FN3O2Se
Molecular Weight: 469.17
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Br.N=C(N)[Se]Cc1ccc(CN2C(=O)C(=O)c3cc(F)cc(Br)c32)cc1
Standard InChI: InChI=1S/C17H13BrFN3O2Se.BrH/c18-13-6-11(19)5-12-14(13)22(16(24)15(12)23)7-9-1-3-10(4-2-9)8-25-17(20)21;/h1-6H,7-8H2,(H3,20,21);1H
Standard InChI Key: FUVZKJDFELQEJA-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 469.17 | Molecular Weight (Monoisotopic): 468.9340 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Dinavahi,SS.; Gowda,R.; Bazewicz,CG.; Battu,MB.; Lin,JM.; Chitren,RJ.; Pandey,MK.; Amin,S.; Robertson,GP.; Gowda,K.. (2020) Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents., 187 [PMID:31887569] [10.1016/j.ejmech.2019.111962] |